Ashlins Pharmaceuticals
1 known investors
Ashlins Pharmaceuticals develops therapeutics for rare and underserved diseases, focusing on programs with scientific validation and accelerated regulatory pathways to deliver treatments where patient options are limited.
BiotechMedical Devices